6 results match your criteria: "Heji Hospital Affiliated with Changzhi Medical College[Affiliation]"
Stimulator of Interferon Genes-Activated Biomimetic Dendritic Cell Nanovaccine as a Chemotherapeutic Booster to Enhance Systemic Fibrosarcoma Treatment.
ACS Nano
September 2024
Department of Hepatobiliary Surgery, Xiang'an Hospital of Xiamen University, Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361102, Fujian, China.
Article Synopsis
- Fibrosarcoma is a serious type of cancer with high invasiveness and recurrence, typically treated with anthracycline drugs like doxorubicin (DOX), which may not be very effective alone.
- New strategies are being explored that combine chemotherapy with immunotherapy, specifically using a dendritic cell (DC) nanovaccine to improve treatment outcomes.
- The innovative nanovaccine, cGAMP@PLGA@CRTM, uses a unique approach that enhances immune response while minimizing side effects from low-dose DOX, presenting a promising new treatment for fibrosarcoma patients.*
Clinical evaluation of AI-assisted screening for diabetic retinopathy in rural areas of midwest China.
PLoS One
October 2022
Department of Foreign Languages, Changzhi Medical College, Changzhi, China.
Background: Although numerous studies have described the application of artificial intelligence (AI) in diabetic retinopathy (DR) screening among diabetic populations, studies among populations in rural areas are rare. The purpose of this study was to evaluate the application value of an AI-based diagnostic system for DR screening in rural areas of midwest China.
Methods: In this diagnostic accuracy study, diabetes mellitus (DM) patients in the National Basic Public Health Information Systems of Licheng County and Lucheng County of Changzhi city from July to December 2020 were selected as the target population.
Errate: Promoting Role of Long Non-Coding RNA Small Nucleolar RNA Host Gene 15 (SNHG15) in Neuronal Injury Following Ischemic Stroke via the MicroRNA-18a/CXC Chemokine Ligand 13 (CXCL13)/ERK/MEK Axis.
Med Sci Monit
September 2022
Department of Neurology, Heji Hospital Affiliated with Changzhi Medical College, Changzhi, Shanxi, China (mainland).
The figure 3D was published as figure 3E. The correct figure 3E is provided below. Reference: Tiezhu Guo, Yueting Liu, Xinliang Ren, Wei Wang, Hanrui Liu.
View Article and Find Full Text PDFPromoting Role of Long Non-Coding RNA Small Nucleolar RNA Host Gene 15 (SNHG15) in Neuronal Injury Following Ischemic Stroke via the MicroRNA-18a/CXC Chemokine Ligand 13 (CXCL13)/ERK/MEK Axis.
Med Sci Monit
August 2020
Department of Neurology, Heji Hospital Affiliated with Changzhi Medical College, Changzhi, Shanxi, China (mainland).
BACKGROUND Long-non-coding RNA (lncRNA) SNHG15 has been reported to be an aberrantly expressed lncRNA in patients with ischemic stroke, but its role in neuronal injury following ischemic stroke remains unclear. We hypothesized that this lncRNA is associated with the pathogenesis of ischemic stroke. MATERIAL AND METHODS A mouse model of ischemic stroke was established by middle cerebral artery occlusion (MCAO).
View Article and Find Full Text PDFComparison and development of machine learning tools for the prediction of chronic obstructive pulmonary disease in the Chinese population.
J Transl Med
March 2020
Department of Respiratory, General Hospital of Tisco (Sixth Hospital of Shanxi Medical University), 2 Yingxin Street, Jiancaoping District, Taiyuan, 030008, Shanxi Province, China.
Background: Chronic obstructive pulmonary disease (COPD) is a major public health problem and cause of mortality worldwide. However, COPD in the early stage is usually not recognized and diagnosed. It is necessary to establish a risk model to predict COPD development.
View Article and Find Full Text PDFEffect of cisplatin-based neoadjuvant chemotherapy on survival in patients with bladder cancer: a meta-analysis.
Clin Invest Med
April 2017
Department of Urology, Heji Hospital Affiliated with Changzhi Medical College, Changzhi, Shanxi 046011, P.R. China.
Purpose: Cisplatin-based neoadjuvant chemotherapy (NAC) has been shown to improve survival in patients with muscle-invasive bladder cancer (MIBC) who underwent radical cystectomy as compared with patients who underwent surgery alone. It has also been suggested as current standard of care in surgically-fit patients with MIBC. This meta-analysis assessed the effect of cisplatin-based NAC on survival in patients with bladder cancer.
View Article and Find Full Text PDF